Format

Send to:

Choose Destination

HIV Seropositivity

Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).

Year introduced: 1988

PubMed search builder options

Subheadings:

Tree Number(s): C02.782.815.616.400.500, C02.800.801.400.500, C20.673.480.500

MeSH Unique ID: D006679

Entry Terms:

  • HIV Seropositivities
  • Seropositivities, HIV
  • Seropositivity, HIV
  • AIDS Seropositivity
  • AIDS Seropositivities
  • Seropositivities, AIDS
  • Seropositivity, AIDS
  • Anti-HIV Positivity
  • Anti HIV Positivity
  • Anti-HIV Positivities
  • Positivities, Anti-HIV
  • Positivity, Anti-HIV
  • HTLV-III Seropositivity
  • HTLV III Seropositivity
  • HTLV-III Seropositivities
  • Seropositivities, HTLV-III
  • Seropositivity, HTLV-III
  • HIV Seroconversion
  • HIV Seroconversions
  • Seroconversion, HIV
  • Seroconversions, HIV
  • HTLV-III Seroconversion
  • HTLV III Seroconversion
  • HTLV-III Seroconversions
  • Seroconversion, HTLV-III
  • Seroconversions, HTLV-III
  • AIDS Seroconversion
  • AIDS Seroconversions
  • Seroconversion, AIDS
  • Seroconversions, AIDS
  • HIV Antibody Positivity
  • Antibody Positivities, HIV
  • Antibody Positivity, HIV
  • HIV Antibody Positivities
  • Positivities, HIV Antibody
  • Positivity, HIV Antibody

Previous Indexing:

See Also:

Supplemental Content

Loading ...
Support Center